Pacira BioSciences
PCRX
PCRX
275 hedge funds and large institutions have $3.04B invested in Pacira BioSciences in 2021 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 105 increasing their positions, 82 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
275
Holders Change
+16
Holders Change %
+6.18%
% of All Funds
4.25%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
45
Increased
105
Reduced
82
Closed
26
Calls
$1.67M
Puts
$5.08M
Net Calls
-$3.42M
Net Calls Change
-$7.42M
Top Buyers
| 1 |
PC
Paulson & Co
New York
|
$103M |
| 2 |
AC
Armistice Capital
New York
|
$78.9M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$142M |
| 4 |
Marshall Wace
London,
United Kingdom
|
$12.4M |
| 5 |
HCM
Hodges Capital Management
Dallas,
Texas
|
$10.1M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
$35.9M |
| 2 |
Wells Fargo
San Francisco,
California
|
$4.99M |
| 3 |
NPIC
Neumeier Poma Investment Counsel
Carmel,
California
|
$19.7M |
| 4 |
Goldman Sachs
New York
|
$10.6M |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
$14.4M |
